[go: up one dir, main page]

GB795174A - Heterocyclic sulphonamides - Google Patents

Heterocyclic sulphonamides

Info

Publication number
GB795174A
GB795174A GB27101/55A GB2710155A GB795174A GB 795174 A GB795174 A GB 795174A GB 27101/55 A GB27101/55 A GB 27101/55A GB 2710155 A GB2710155 A GB 2710155A GB 795174 A GB795174 A GB 795174A
Authority
GB
United Kingdom
Prior art keywords
sulphenamide
sulphonamides
thiadiazole
heterocyclic
sulphonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB27101/55A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB795174A publication Critical patent/GB795174A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70Sulfur atoms
    • C07D277/76Sulfur atoms attached to a second hetero atom
    • C07D277/80Sulfur atoms attached to a second hetero atom to a nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Lubricants (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention comprises C-polyheterocyclic sulphonamides, i.e those containing 2 or more hetero atoms in the heterocycle, containing a sulphur atom in the alpha position to the sulphonamide group and/or having the heterocycle at least partly reduced; compounds of the formula R-SO2NR1R11 wherein -NR1R11 is a primary, secondary or tertiary amido group and R is a partially or wholly reduced thiazole, oxazole, imidazole, pyrimidine, pyrazine, pyridazine, oxazine, thiazine or thiadiazole radical; 6-ethoxybenzothiazole-2-sulphonamide; 4-phenyl-5-thiono-4 : 5-dihydro-1 : 3 : 4 - thiadiazole - 2 - sulphonamide; 6 - carboxamidobenzothiazole - 2 - sulphonamides and 6 - carboxamido - 4 - hydroxy - pyrimidine-2-sulphonamides containing from 1 to 8 carbon atoms in the carboxamido radical; and the preparation of C-heterocyclic sulphonamides in general by the oxidative condensation of a C-heterocyclic thiol and ammonia or a primary or secondary amine followed by oxidation of the resulting sulphenamide. In a modification of this process the sulphenamide is prepared by reacting a C-heterocyclic thiol with an N-chloramine. Preferably, the oxidative condensation is brought about with the aid of a hypohalite or a halogen in aqueous alkaline solution, with addition of a water-miscible solvent, e.g. ethanol or dioxan, if necessary, the temperature preferably being kept below 30 DEG C. and advantageously at 0 DEG to 10 DEG C. Acid oxidation or a two-stage process via the disulphide may also be used. The oxidation of the sulphenamides to the sulphonamides is advantageously achieved with aqueous potassium permanganate in a suitable solvent, although other oxidizing agents such as alkaline hydrogen peroxide and sodium peroxide, hydrogen peroxide in acetic acid, chromic acid, nitric acid or permanganic acid can also be used, at temperatures normally between 0 DEG and 50 DEG C. In examples: (1) 6-ethoxybenzothiazole-2-thiol in sodium hydroxide solution reacts with sodium hypochlorite solution and ammonium hydroxide at a low temperature to give 6-ethoxybenzothiazole-2-sulphenamide which on permanganate oxidation gives the corresponding sulphonamide; (2) 6-acetamidobenzothiazole-2-sulphenamide, the corresponding 4- and 6-propionamido-, 4- and 6-valeramido-, 4- and 6-caprylamido-, 4- and 6-benzamido- and 4-carboxy-6-benzamido-compounds, and the sulphonamides corresponding to all these sulphenamides are similarly prepared; (3) 4-phenyl-5-thiono-4 : 5-dihydro-1 : 3 : 4-thiadiazole-2-sulphenamide is prepared either as in (1) or by treating the corresponding disulphide with alcoholic ammonia and is then oxidized as in (1) to the corresponding sulphonamide; 4 : 4 : 6-trimethyl-1 : 2 : 3 : 4-tetrahydropyrimidine-2-, 4 : 5-dihydrothiazole-2-, 4-methyl - 4 : 5 - dihydrothiazole - 2 -, 5 : 5- di-methyl - 4 : 5 - dihydrothiazole - 2 -, 5 - ethyl - 5 - methyl - 4 : 5 - dihydrothiazole - 2 -, imidazoline-2- and 2 : 4-diketo-1 : 2 : 3 : 4-tetrahydropyrimidine-6-sulphonamides are similarly prepared; (4) 6-acetamido-4-acetoxypyrimidine 2-thiol (prepared from 6-amino-4-hydroxypyrimidine-2-thiol and acetic anhydride in pyridine) is reacted as in (1) to give 6-acetamido-4-hydroxypyrimidine-2-sulphenamide and this is oxidized as in (1) to the corresponding sulphonamide; the 6-propionamido-, 6-valeramido-, 6-caprylamido- and 6-benzamido-compounds are similarly obtained; (5) 5-acetamido-1 : 3 : 4-thiadiazole-2-sulphenamide and the corresponding sulphonamide, and the corresponding 5-propionamido-, 5-valeramido-, 5-caprylamido- and 5-benzamido-compounds are prepared as in (1). Reference is also made to the preparation of sulphonamides from thiols containing other heterocyclic radicals with one, two or more hetero atoms, not reduced or wholly or partly reduced, substituted or unsubstituted, which may be fused with one or more homo or heterocyclic rings. Specific reference is made to isoxazole, pteridine, purine, pyrrole, isoxazoline, pyrrolidine, tetrazole, triazole, pyridine, thiophene, furan, pyran, thiapyran, benzimidazole, naphthothiazole, benzoxazole, quinoline, and pyrido[2 : 1-c-]-s-triazole, in addition to the rings referred to above, to dithiols such as 1 : 2 : 4-thiadiazole-3 : 5- and -2 : 5-dithiols, to alkyl, aryl, aralkyl, alkoxy, carboxamido, halogen, thiono, oxo and hydroxy substituents in the heterocyclic rings and these and nitro groups in the fused-on aromatic rings, to N-alkyl-, N : N-dialkyl-, N-2-aminoethyl-, N-cycloalkyl-, N-alkyl-N-cycloalkyl-, N-2-pyridyl-, N-2-thiazolyl-, N-2-pyrimidyl-, N-phenyl-, N-methyl-N-phenyl-, N-2-thienyl-, N-thenyl-, N-2-furyl-, N-tolyl-, N-benzyl- and N-phenylethyl-sulphonamides and to sulphonamides in which the amide nitrogen forms part of a heterocycle such as piperidine, pyrrolidine, piperazine and morpholine and alkyl substituted derivatives thereof. Specification 377,730, [Group IV], is referred to.ALSO:Heterocyclic sulphenamides wherein the sulphenamide group is attached to a carbon atom of the heterocycle are used as vulcanization accelerators in the compounding and vulcanization of rubber. Specific reference is made to the use of 6-ethoxybenzothiazole-2-sulphenamide, 6-acetamidobenzothiazole-2-sulphenamide, 4-phenyl-5-thiono-4 : 5-dihydro-1 : 3 : 4-thiadiazole-2-sulphenamide and 5-acetamido-1 : 3 : 4-thiadiazole-2-sulphenamide as vulcanization accelerators.
GB27101/55A 1954-10-13 1955-09-22 Heterocyclic sulphonamides Expired GB795174A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US795174XA 1954-10-13 1954-10-13

Publications (1)

Publication Number Publication Date
GB795174A true GB795174A (en) 1958-05-21

Family

ID=22151064

Family Applications (1)

Application Number Title Priority Date Filing Date
GB27101/55A Expired GB795174A (en) 1954-10-13 1955-09-22 Heterocyclic sulphonamides

Country Status (1)

Country Link
GB (1) GB795174A (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3478030A (en) * 1966-06-27 1969-11-11 Abbott Lab Benzamide substituted anilino aminopyrimidines
US3839303A (en) * 1971-01-18 1974-10-01 Monsanto Co Inhibiting premature vulcanization with aminothiopyrimidines
JPS544379B1 (en) * 1971-01-18 1979-03-06
US4483864A (en) * 1983-02-04 1984-11-20 University Of Iowa Research Foundation Non-classical topical treatment for glaucoma
US4975449A (en) * 1983-02-04 1990-12-04 University Of Iowa Research Foundation Topical treatment of glaucoma with 2-benzothiazolesulfonamide derivative
US5079305A (en) * 1989-09-05 1992-01-07 Monsanto Company Rubber compositions comprising sulfenimide accelerators
US5374689A (en) * 1992-06-05 1994-12-20 Monsanto Company Rubber compositions containing 2-pyrazine sulfenamides
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US6878703B2 (en) 2000-11-21 2005-04-12 Sankyo Company, Limited Pharmaceutical composition
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
CN100387584C (en) * 2005-07-05 2008-05-14 杭州保灵有限公司 A kind of preparation method of methazolamide
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2008089521A1 (en) 2007-01-25 2008-07-31 Verva Pharmaceuticals Ltd Insulin sensitisers and methods of treatment
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2015012205A1 (en) 2013-07-23 2015-01-29 第一三共株式会社 Medicine for preventing or treating hypertension
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3478030A (en) * 1966-06-27 1969-11-11 Abbott Lab Benzamide substituted anilino aminopyrimidines
US3839303A (en) * 1971-01-18 1974-10-01 Monsanto Co Inhibiting premature vulcanization with aminothiopyrimidines
JPS544379B1 (en) * 1971-01-18 1979-03-06
US4483864A (en) * 1983-02-04 1984-11-20 University Of Iowa Research Foundation Non-classical topical treatment for glaucoma
US4636515A (en) * 1983-02-04 1987-01-13 University Of Iowa Research Foundation Non-classical topical treatment for glaucoma
US4975449A (en) * 1983-02-04 1990-12-04 University Of Iowa Research Foundation Topical treatment of glaucoma with 2-benzothiazolesulfonamide derivative
US5079305A (en) * 1989-09-05 1992-01-07 Monsanto Company Rubber compositions comprising sulfenimide accelerators
US5374689A (en) * 1992-06-05 1994-12-20 Monsanto Company Rubber compositions containing 2-pyrazine sulfenamides
US6878703B2 (en) 2000-11-21 2005-04-12 Sankyo Company, Limited Pharmaceutical composition
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
CN100387584C (en) * 2005-07-05 2008-05-14 杭州保灵有限公司 A kind of preparation method of methazolamide
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2008089521A1 (en) 2007-01-25 2008-07-31 Verva Pharmaceuticals Ltd Insulin sensitisers and methods of treatment
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2015012205A1 (en) 2013-07-23 2015-01-29 第一三共株式会社 Medicine for preventing or treating hypertension
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof
EP4470609A2 (en) 2019-01-18 2024-12-04 Astrazeneca AB Pcsk9 inhibitors and methods of use thereof

Similar Documents

Publication Publication Date Title
GB795174A (en) Heterocyclic sulphonamides
GB940169A (en) A process for preventing darkening and precipitates in photographic developers
ES384420A1 (en) Certai 1,2,4-oxa- and -thiadiazol-5-ylthioalkanoic acid derivatives
IE37572B1 (en) 1-aminouracil compounds a process for their production and their use as herbicides
GB965009A (en) New 2,3-dimercapto-quinoxalines
US2835670A (en) Aminoazoledisulfides
HUT40118A (en) Process for preparing 5-/azolyl-oxy-phenyl-carbamoyl/-barbituric acid-derivatives
US3265706A (en) Processes for preparing certain 2-substituted benzimidazole compounds
GB1527807A (en) Thiazolines
US3796710A (en) 1h-2,1,4-benzothiadiazines
GB961917A (en) Process for the production of new 3-hydroxy-benzisoxazoles
GB759675A (en) Improvements in the manufacture of merocyanine dyes
GB687760A (en) Improvements relating to the preparation of heterocyclic sulphonamides
JPH0586040A (en) Process for producing 2-aminodithiothiazole and 2-aminotrithiothiazole
YU126483A (en) Process for obtaining new cephalosporine derivatives
GB1412546A (en) Morpholine derivatives
ES387561A1 (en) 2-acylamino-1,3,4-thiadiazole-(thi)one-(5)compounds and herbicidal compositions
GB841419A (en) Method for the preparation of aminodithiothiazoles
GB846573A (en) ºÔ-substituted benzene sulphonamides and processes for the manufacture thereof
Bon et al. The synthesis of 2-substituted imino-3-amino-4-thiazolidones
US2393507A (en) Composition of matter
GB922708A (en) Production of sulfoxides and sulfones
SU520363A1 (en) Derivatives of 3-thiocarbamylthiomethylbenzthiazolthione-2 as accelerators of sulfur vulcanization of rubber compounds based on general purpose rubbers
GB1003784A (en) Basically substituted derivatives of halogeno-4-azaphenthiazines
KR950702565A (en) Tricyclic cefem sulphones as elastase inhibitors